Taufiqur Rahman Bhuiyan Selected Research

Cholera Toxin

1/2021	Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.
11/2019	Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba.
1/2019	Assessment of disease specific immune responses in enteric diseases using dried blood spot (DBS).
1/2018	Assessing antigen specific HLA-DR+ antibody secreting cell (DR+ASC) responses in whole blood in enteric infections using an ELISPOT technique.
1/2016	Enumeration of Gut-Homing β7-Positive, Pathogen-Specific Antibody-Secreting Cells in Whole Blood from Enterotoxigenic Escherichia coli- and Vibrio cholerae-Infected Patients, Determined Using an Enzyme-Linked Immunosorbent Spot Assay Technique.
1/2016	O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.
10/2013	Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taufiqur Rahman Bhuiyan Research Topics

Disease

28	Cholera 01/2022 - 10/2005
22	Infections 10/2021 - 10/2005
7	Diarrhea 10/2021 - 12/2011
3	Typhoid Fever (Typhoid) 01/2019 - 11/2017
2	Malnutrition (Nutritional Deficiencies) 01/2021 - 01/2013
2	Convalescence 01/2016 - 08/2015
1	Severe Acute Respiratory Syndrome 06/2022
1	Coronavirus Infections 03/2022
1	COVID-19 03/2022
1	Hepatitis E 12/2021
1	Dehydration (Water Stress) 01/2021
1	Reinfection 12/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Rotavirus Infections 11/2018
1	Communicable Diseases (Infectious Diseases) 12/2011

Drug/Important Bio-Agent (IBA)

17	AntigensIBA 01/2021 - 02/2009
14	AntibodiesIBA 03/2022 - 02/2009
14	Immunoglobulin A (IgA)IBA 01/2021 - 02/2009
11	Immunoglobulin G (IgG)IBA 03/2022 - 02/2009
11	VaccinesIBA 12/2021 - 10/2005
10	Cholera Vaccines FDA Link 01/2022 - 05/2009
9	LipopolysaccharidesIBA 01/2021 - 12/2011
8	Immunoglobulin M (IgM)IBA 03/2022 - 05/2014
8	O Antigens (O Antigen)IBA 07/2021 - 05/2014
7	Cholera ToxinIBA 01/2021 - 10/2013
5	Blood Group Antigens (Blood Groups)IBA 10/2021 - 02/2009
4	EnzymesIBA 01/2019 - 02/2009
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 04/2019 - 10/2013
3	ImmunosorbentsIBA 01/2019 - 02/2009
2	Monoclonal AntibodiesIBA 01/2021 - 11/2020
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 12/2010
2	MicronutrientsIBA 11/2016 - 01/2013
2	Polysaccharides (Glycans)IBA 01/2016 - 01/2015
1	ChAdOx1 nCoV-19IBA 06/2022
1	shancholIBA 01/2022
1	Lipopolysaccharide ReceptorsIBA 01/2021
1	Neuraminidase (Sialidase)IBA 01/2021
1	SaltsIBA 11/2020
1	Ion Channels (Ion Channel)IBA 11/2020
1	IntegrinsIBA 12/2019
1	CD40 Ligand (CD40L)IBA 04/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	Rotavirus VaccinesIBA 11/2018
1	InterferonsIBA 01/2018
1	cholera vaccine CVD 103-HgRIBA 01/2018
1	RIX4414 vaccineIBA 01/2018
1	Dual OxidasesIBA 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Hemolysin Proteins (Hemolysins)IBA 11/2017
1	LeptinIBA 08/2015
1	Conjugate VaccinesIBA 01/2015
1	squaric acidIBA 01/2015
1	Tetanus ToxinIBA 01/2015
1	DukoralIBA 10/2013
1	CytokinesIBA 08/2012
1	Lewis Blood Group AntigensIBA 12/2011
1	ABO Blood-Group SystemIBA 12/2011
1	Indicators and Reagents (Reagents)IBA 10/2005

Therapy/Procedure

1	Fluid Therapy (Oral Rehydration Therapy) 01/2018